These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27623777)
1. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling. Zindel D; Engel S; Bottrill AR; Pin JP; Prézeau L; Tobin AB; Bünemann M; Krasel C; Butcher AJ Biochem J; 2016 Nov; 473(22):4173-4192. PubMed ID: 27623777 [TBL] [Abstract][Full Text] [Related]
2. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation. Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311 [TBL] [Abstract][Full Text] [Related]
3. Translating in vitro ligand bias into in vivo efficacy. Luttrell LM; Maudsley S; Gesty-Palmer D Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495 [TBL] [Abstract][Full Text] [Related]
4. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor. van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578 [TBL] [Abstract][Full Text] [Related]
5. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling. Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997 [TBL] [Abstract][Full Text] [Related]
6. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids. Candelario J; Tavakoli H; Chachisvilis M PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710 [TBL] [Abstract][Full Text] [Related]
7. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation. Yang Y; Wang B Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699 [TBL] [Abstract][Full Text] [Related]
12. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption. Bohinc BN; Gesty-Palmer D Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967 [TBL] [Abstract][Full Text] [Related]
13. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments. Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722 [TBL] [Abstract][Full Text] [Related]
14. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex. Wehbi VL; Stevenson HP; Feinstein TN; Calero G; Romero G; Vilardaga JP Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1530-5. PubMed ID: 23297229 [TBL] [Abstract][Full Text] [Related]
15. Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor. Kim BH; Pereverzev A; Zhu S; Tong AOM; Dixon SJ; Chidiac P Cell Signal; 2018 Jun; 46():103-112. PubMed ID: 29501726 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways. Cupp ME; Nayak SK; Adem AS; Thomsen WJ J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330 [TBL] [Abstract][Full Text] [Related]